82152 Planegg-Martinsried, de
+49 (89) 700763-66
4SC AG to present at the 19th Annual BIO CEO & Investor Conference 2017
Dr Loveridge‘s presentation will take place on Monday, 13 February 2017 at 4.30 p.m. EST in the Duke of Windsor room during the conference's Oncology Track. Additionally, he will be available for one-on-one meetings at the conference.
About BIO CEO & Investor Conference
BIO CEO & Investor Conference is one of the largest annual conferences dedicated to emerging publicly traded as well as private biotech companies. It serves as an investor and networking conference dedicated towards providing an excellent opportunity to biotechnology and life sciences companies to present to, and meet with, institutional investors, analysts and pharmaceutical executives. The conference features plenary sessions, educational sessions, company presentations, and one-on-one meetings.
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of 4SC as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond 4SC’s control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. 4SC expressly disclaims any obligation or undertaking to release any updates or revisions to any such statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.